Medicare Enrolled

Dr. Luis Barreras, M.D., FACP

Hematology & Oncology · Ft Lauderdale, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
6405 N FEDERAL HWY, Ft Lauderdale, FL 33308
9547710692
In practice since 2005 (20 years)
NPI: 1780676346 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Barreras from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Barreras? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Barreras

Dr. Luis Barreras is a hematology & oncology specialist in Ft Lauderdale, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Barreras performed 4,870 Medicare services across 913 unique beneficiaries.

Between the years covered by Open Payments, Dr. Barreras received a total of $21,574 from 84 pharmaceutical and/or device companies across 969 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Barreras is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 29% volume in FL $21,574 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,870
Medicare services
Top 29% in FL for hematology & oncology
913
Unique beneficiaries
$21
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~244 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Dexamethasone injection (steroid) 1,858 $0 $0
Anti-nausea injection (ondansetron/Zofran) 1,048 $0 $0
Complete blood count (CBC) with differential 478 $8 $15
Office visit, established patient (30-39 min) 427 $96 $272
Office visit, established patient (20-29 min) 205 $65 $196
Blood draw (venipuncture) 158 $8 $16
Administration of chemotherapy into vein, 1 hour or less 126 $103 $297
Drug injection, under skin or into muscle 97 $11 $30
Injection, diphenhydramine hcl, up to 50 mg 65 $1 $2
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 63 $22 $63
Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services 63 $72 $140
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 57 $49 $150
New patient office visit (45-59 min) 57 $131 $344
Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion 38 $15 $40
Office visit, established patient, complex (40-54 min) 37 $141 $336
Injection of additional new drug or substance into vein 35 $12 $36
Initial hospital admission, moderate complexity 30 $107 $272
Office visit, established patient (10-19 min) 17 $43 $123
New patient office visit, complex (60-74 min) 11 $180 $461
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.2% high complexity
66.3% medium
30.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$21,574
Total received (2018-2024)
Avg $3,082/year across 7 years
Top 25% in FL for hematology & oncology
84
Companies
969
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,070 (88.4%)
Other
Charitable contributions, space rental, and other categories
$1,823 (8.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$681 (3.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,348
2023
$3,777
2022
$3,226
2021
$3,974
2020
$1,647
2019
$2,430
2018
$2,172

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$2,423
AstraZeneca Pharmaceuticals LP
$2,184
PFIZER INC.
$1,601
Janssen Biotech, Inc.
$1,158
E.R. Squibb & Sons, L.L.C.
$917
Rigel Pharmaceuticals, Inc.
$887
Celgene Corporation
$713
Merck Sharp & Dohme LLC
$659
Eisai Inc.
$601
Genentech USA, Inc.
$596
Merck Sharp & Dohme Corporation
$574
Incyte Corporation
$532
Lilly USA, LLC
$471
Astellas Pharma US Inc
$460
Seagen Inc.
$418
GENZYME CORPORATION
$358
GlaxoSmithKline, LLC.
$351
Amgen Inc.
$325
Takeda Pharmaceuticals U.S.A., Inc.
$321
EMD Serono, Inc.
$253
Adaptive Biotechnologies Corporation
$238
Dova Pharmaceuticals
$222
JAZZ PHARMACEUTICALS INC.
$220
EISAI INC.
$220
Bayer HealthCare Pharmaceuticals Inc.
$213
BeiGene USA, Inc.
$207
Regeneron Healthcare Solutions, Inc.
$189
INSYS Therapeutics Inc
$188
ARRAY BIOPHARMA INC
$187
Pharmacosmos Therapeutics Inc.
$183
ABBVIE INC.
$172
SOBI, INC
$170
NOVARTIS PHARMACEUTICALS CORPORATION
$167
Daiichi Sankyo Inc.
$166
Karyopharm Therapeutics Inc.
$160
Sobi, Inc
$160
Kyowa Kirin, Inc.
$152
Coherus Biosciences Inc.
$138
Ipsen Biopharmaceuticals, Inc
$130
PUMA BIOTECHNOLOGY, INC.
$129
Novocure Inc.
$124
AbbVie Inc.
$121
TAIHO ONCOLOGY, INC.
$120
Exelixis Inc.
$119
Bayer Healthcare Pharmaceuticals Inc.
$115
SERVIER PHARMACEUTICALS LLC
$95
MEDIVATION FIELD SOLUTIONS LLC
$85
Foundation Medicine, Inc.
$81
Alexion Pharmaceuticals, Inc.
$72
Deciphera Pharmaceuticals Inc.
$68
Boehringer Ingelheim Pharmaceuticals, Inc.
$67
AbbVie, Inc.
$63
Taiho Oncology, Inc.
$62
Janssen Pharmaceuticals, Inc
$56
Alnylam Pharmaceuticals Inc.
$54
Jazz Pharmaceuticals Inc.
$50
RECORDATI_RARE_DISEASES_INC.
$50
Blueprint Medicines Corporation
$48
Apellis Pharmaceuticals, Inc.
$47
Octapharma USA, Inc.
$46
Mirati Therapeutics, Inc.
$43
Myriad Genetic Laboratories, Inc.
$43
Gilead Sciences, Inc.
$40
Acceleron Pharma, Inc.
$37
Global Blood Therapeutics, Inc.
$35
Legend Biotech USA Inc.
$33
Amneal Pharmaceuticals LLC
$33
Agios Pharmaceuticals, Inc.
$32
Aveo Pharmaceuticals, Inc.
$26
Biocon Biologics Inc
$24
ACCORD HEALTHCARE, INC.
$24
Azurity Pharmaceuticals, Inc.
$24
Sumitomo Pharma America, Inc.
$23
TerSera Therapeutics LLC
$22
Blue Earth Diagnostics Limited
$22
Geron Corporation
$22
Emmaus Medical, Inc.
$21
ADC Therapeutics America, Inc.
$21
Puma Biotechnology, Inc.
$20
Teva Pharmaceuticals USA, Inc.
$18
Advanced Accelerator Applications
$17
Acrotech Biopharma Inc.
$17
Pharmacyclics LLC, An AbbVie Company
$14
Organon LLC
$9
Top 3 companies account for 28.8% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · ALUNBRIG · AVASTIN · AYVAKIT · Abraxane · Alecensa · Aliqopa · Aranesp · Avastin · BAVENCIO · BELEODAQ · BENDEKA · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABLIVI · CABOMETYX · CALQUENCE · CAMCEVI · CARVYKTI · CERDELGA · CYRAMZA · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · EMEND · EMPLICITI · ENHERTU · ENJAYMO · ERBITUX · ERLEADA · Empaveli · Endari · Enhertu · Erleada · FOTIVDA · FOUNDATIONONE · FRUZAQLA · GILOTRIF · GIVLAARI · Gazyva · Halaven · IBRANCE · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · Inrebic · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LENVIMA · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · NINLARO · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Ogivri · Oncology · Onivyde · PADCEV · PANZYGA · PEMAZYRE · PIQRAY · PLUVICTO · POSLUMA · POTELIGEO · PROMACTA · Phesgo · Polivy · Pomalyst · Poteligeo · Prolia · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · RYTELO · Reblozyl · Revlimid · Rezlidhia · SARCLISA · SCEMBLIX · SHINGRIX · SOLIRIS · SOMATULINE DEPOT · SUBSYS · SUTENT · SYLVANT · SYNDROS · Somatuline Depot · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TEPMETKO · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tecentriq · Tibsovo · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VIVIMUSTA · VONJO · VONVENDI · VOTRIENT · VYXEOS · Venclexta · Vitrakvi · Vyloy · XALKORI · XARELTO · XPOVIO · XTANDI · Xofigo · Xospata · Xtandi · ZEJULA · ZEPZELCA · ZOLADEX · clonoSEQ · myChoice CDx · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (88%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $443 per 100 Medicare services performed
Looking for a hematology & oncology specialist in Ft Lauderdale?
Compare hematology & oncology specialists in the Ft Lauderdale area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
112
Per 100K population
5.8
County median income
$74,534
Nearest hospital
HOLY CROSS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Barreras is a clinical cardiology specialist, with above-average Medicare volume (top 29% in FL), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Barreras experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Barreras performed 1,858 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Barreras receive payments from pharmaceutical companies?
Yes. Dr. Barreras received a total of $21,574 from 84 companies across 969 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Barreras's costs compare to other hematology & oncology specialists in Ft Lauderdale?
Dr. Barreras's average Medicare payment per service is $21. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Barreras) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →